Evidence map›Paper›PMID 32284591›Full record

ReviewNature immunology2020

The RNA modification N

Ziv Shulman, Noam Stern-Ginossar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 254 papers.

0numbers the graph read from it
0cells of the map it votes in
254citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

254 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. METTL3-mCurrent medical science · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Meta-unstable mRNAs in activated CD8Nature communications · 2026
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

194 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ziv ShulmanDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel. ziv.shulman@weizmann.ac.il.ORCID http://orcid.org/0000-0002-9604-212X
Noam Stern-GinossarDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. noam.stern-ginossar@weizmann.ac.il.ORCID http://orcid.org/0000-0003-3583-5932

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protection from harmful pathogens depends on activation of the immune system, which relies on tight regulation of gene expression. Recently, the RNA modification N

Indexed as

Adaptive ImmunityAdenosineAnimalsCell DifferentiationHumansImmune SystemImmunity, InnateImmunomodulationRNARNA Processing, Post-TranscriptionalAdenosineN-methyladenosineRNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.